Tinea Corporis Market Research Report: By drug type (antifungals and others), by diagnosis (physical exam, imaging test, and others), by treatment (antifungal shampoos and others), by end-users (hospital pharmacies and others)- Forecast till 2027
Market Highlights:
Tinea corporis is a skin infection of arms and legs and it can also occur on any part of body. Tinea corporis is mainly caused by fungus known as dermatophyte. This infection can also acquire from person to person via direct skin contact with the infected person. It is most commonly known as ringworm infection. This infection can also spread from different other sources such as hair brushes, combs, bed linen, of affected person.
Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/6838
Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person.
Top Industry Key players:
Some of the key players in the global tinea corporis market are
Taro Pharmaceuticals. Inc.
Teva Pharmaceuticals Inc.
Glenmark Pharmaceuticals Inc
Breckenridge Pharmaceutical Inc.
NorthStar Rx LLC
Aurobindo Pharma Limited
and Camber Pharmaceuticals Inc.
AvKare Inc.
Novartis AG
Sebela Pharmaceuticals Inc.
Bayer AG
Blueberry Therapeutics Ltd
Perrigo Company.
Market Segmentation:
Global tinea corporis market is segmented into drug type, diagnosis, treatment and end-users.
Global Tinea Corporis Market by Drug Type
Antifungals
Steroids
Anti-Infective Combinations
Global Tinea Corporis Market, by Diagnosis
Physical Exam
Imaging Tests
Wood lamp (black light) examination
Microscopy using potassium hydroxide (KOH)
Fungal culture
Skin biopsy
Others
Global Tinea Corporis Market, by Treatment
Antifungal shampoos
Antifungal creams
Drugs
Others
Global Tinea Corporis Market, by End-Users
Hospital Pharmacies
Drug Stores
Online Pharmacies
Dermatology hospitals
Others
Regional Market Summary
Geographically, the America holds the highest market share for tinea corporis market and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region
Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.
Intended Audience
Manufacturers and Suppliers
Hospitals and Clinics
Laboratories and Associations
Research Institutes
Dermatology Clinics
Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Comments